Litebamine
Litebamine is a phenanthrene alkaloid with antiplatelet activity. Litebamine potently targets arachidonic acid- and collagen-induced platelet aggregation, but shows no activity against thrombin-induced aggregation. Litebamine inhibits arachidonic acid- and collagen-induced ATP release and thromboxane B2 production in rabbit platelets, without altering cyclic AMP levels or phosphoinositide breakdown in rabbit platelets. Litebamine has no effect on platelet-activating factor- or U46619 (HY-108566)-induced aggregation, nor does it affect [3H] inositol monophosphate production in rabbit platelets induced by collagen, platelet-activating factor or thrombin.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 137031-56-2
- Formule: C20H21NO4
- Masse moléculaire:339.39
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
In Vitro
Litebamine (1.5-60 μM; 3 min) suppresses adrenaline- and ADP-induced secondary aggregation (but not primary aggregation) in human platelet-rich plasma[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:human platelet-rich plasma
-
Concentration:1.5-60 μM
-
Incubation Time:3 min
-
Result:Completely inhibited at 30 μM for adrenaline-induced secondary aggregation and 60 μM for ADP-induced secondary aggregation.
Chemical Information
-
CAS No. 137031-56-2
-
Masse moléculaire 339.39
-
Formule C20H21NO4
-
SMILES
OC(C=C1C=CC2=C(CCN(C3)C)C3=C4O)=C(OC)C=C1C2=C4OC
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)